Oculogenex
PrivateLast Round
Grant
May 1, 2022
Total Funding Raised
$1.28M
Company Overview
Oculogenex is a biotechnology company developing a regenerative gene therapy to treat retinal disorders such as dry age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Space Technology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oculogenex Comparables
Compare Oculogenex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Biotherapeutics, Inc. | 84% | |
| Complement Therapeutics GmbH | 82% | |
| Beacon Therapeutics | 81% | |
Oculogenex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2022 | ||||
| Grant | Oct 28, 2021 | ||||
| Grant | May 1, 2021 | ||||
| Grant | Feb 6, 2021 |
Key People
Founding team and executive leadership
Oculogenex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Grant |
| The Winning Pitch Challenge | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2022
Received $1M grant from the National Science Foundation.
- Nov 2, 2021
Received grant funding from Boeing and MassChallenge.
Oculogenex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oculogenex's valuation, stock price, and market status.